IPO pricing is expected within 1-2 days of effectiveness. Monitor for final pricing announcement and first-day trading performance on Nasdaq under ticker ETRA. The company's lead candidate ipsoprubart is in a registrational trial for sHLH, a key catalyst to watch post-IPO.
Price Chart
Executive Summary
Electra Therapeutics' S-1 registration statement for its IPO of common stock has been declared effective by the SEC as of September 17, 2026. The company can now proceed to price and close its initial public offering, which is critical to resolve a going-concern doubt and fund operations into 2029. Pricing is expected imminently, likely within 1-2 days.
Key Facts
- EFFECT notice filed September 17, 2026, declaring S-1 registration effective
- IPO of 21,666,667 shares of common stock at expected price range of $14.00-$16.00 per share
- Net proceeds of approximately $296.6 million (at midpoint) expected to fund operations into 2029
- Lead candidate ipsoprubart in global registrational trial for sHLH; ELA822 also advancing
- Company had going-concern doubt prior to IPO; effectiveness resolves near-term financing risk
Financial Impact
IPO expected to raise ~$296.6 million net (at midpoint of $14.00-$16.00 range), providing cash runway into 2029
Risk Factors
- IPO pricing below expected range would reduce proceeds and shorten cash runway
- Clinical development risk for ipsoprubart and ELA822; no approved products yet
- Post-IPO dilution: 21.67M shares offered, plus underwriter option for additional shares
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002994 |
| Document: 9999999995-26-002994-index.html | 9999999995-26-002994 |
| Document: 9999999995-26-002994.txt | 9999999995-26-002994 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.37 (−26.26%) |
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.37 (−26.26%) |
Sep 25, 2026 4w ago | SC 13D | $11.32 $11.35 | ▲ +0.27% | ▲ +0.45% | $8.37 (−26.06%) |
Sep 23, 2026 4w ago | Insider Cluster | $11.82 $11.55 | ▼ −2.28% | ▼ −2.83% | $8.37 (−29.19%) |
Sep 21, 2026 4w ago | 3 | $13.62 $12.67 | ▼ −6.97% | ▼ −6.25% | $8.37 (−38.55%) |
Sep 18, 2026 5w ago | 424B4 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | EFFECT | $13.25 $13.92 | ▲ +5.06% | ▲ +3.51% | $8.37 (−36.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers